Aplicación de índice combinado de afectación en pacientes con fibromialgia ICAF: un estudio transversal.: Publicado originalmente en la revista El Dolor, 64: 12-8; 2015

Carmen Altamirano; Javier Rivera; Jaime Leppe

doi:10.47924/neurotarget2016191

Authors

Carmen Altamirano Psicomed Estudios Médicos, Antofagasta, Chile.
Javier Rivera Unidad de Reumatología del Hospital Universitario Gregorio Marañón, Madrid, España.
Jaime Leppe Carrera de Kinesiología, Facultad de Medicina, Universidad del Desarrollo, Clínica Alemana. Chile.

DOI:

https://doi.org/10.47924/neurotarget2016191

Keywords:

Fibromyalgia, ICAF questionnaire, Survey

Abstract

Introduction: Fibromyalgia syndrome is a rheumatic disease of unknown origin, which mainly affects women and causes various symptoms, including pain, sleep disorders, depression and fatigue, thus affecting all aspects of the patient’s life. Currently in our country we have few studies on quality of life and functionality in this patient group.
Objectives: To describe the severity index in patients suffering from Fibromyalgia using the Combined Index Questionnaire (ICAF). To evaluate the applicability of ICAF in the Chilean population.
Materials and Methods: This is a descriptive observational study in which Chilean women affected by Fibromyalgia belonging to the COFIBROCHILE Corporation participated. The ICAF questionnaire was implemented in its original format, in a self-applied way, and the personal and socio-demographic background of the participants was also recorded. For analysis of the results, the results of the T-score (mean 50, SD 10) were standardized. The results are presented in range 50 and percentile 10, using the STATA 10.2 statistical package.
Results: Participants were a total of 43 women, median age 48 years, ranging between 27 to 85 years, with a fibromyalgia diagnosis of 5.5 years average, within a range of 0-16 years, where 89% of the patients have had at least 12 years of study, and 95% have at least one co morbid condition such as irritable bowel syndrome, arthritis, hypertension, rheumatoid arthritis or depression. ICAF total score was 47.2 with a range of 22.3- 75.8. Description according to evaluation factors resulted in thefollowing scores: Physical = 48.7, Emotional = 48.24, activecoping = 55.4 and passive coping = 52.7.
Conclusion: The group reported a severity index within the range of the average standardized mean, presenting a multidimensional commitment. Final results are consistent with similar studies in populations sharing same health and socio-demographic characteristics. The applicability of the questionnaire was fast, without need of further intervention to support its understanding. The ICAF questionnaire seems to be a useful tool in the characterization of the multidimensional severity of fibromyalgia, in the assessment of a kinesthetic intervention. Prior to its validation process, cultural adaptations are recommended.

Metrics

Metrics Loading ...

References

Choy E, Perrot s, León t, Kaplan J, Petersel D, Anna G, Kramer E. (2010). A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010 Apr 26;10:102.

Wolfe F, Smythe HA, Yunus MB. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-72.

Rivera J, Alegre C, Ballina FJ, Carbonell J, Carmona L, Castel B, et al. (2006). Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia. Reumatol Clin. 2006;2 Supl 1:S55-66.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10.

Esteve-Vives J, Rivera J, Vallejo M, y Grupo ICAF*. (2010). Evaluación de la capacidad funcional en fibromialgia. Análisis comparativo de la validez de constructo de tres escalas. Reumatol Clin. 2010;6(3):141-4.

Vallejo M, Rivera J, Esteve-Vives J, Group ICAF. (2010). Developmentof a self- reporting tool to obtain a Combined Index of Severity of Fibromyalgia (ICAF*). Vallejo et al. Health and Quality of Life Outcomes 2010, 8:2

Vallejo M, Rivera J, Esteve-Vives J, Rejas J, and Group ICAF. (2011). Aconfirmatory study if the Combined Index of Severety of Fibromyalgia (ICAF*): factorial structure, realiability and sensitivity to change. Vallejo et al. Health and Quality of Life Outcomes 2011, 9: 39.

Miranda J, Guerra C, Letelier C, Contador R, Jaque J,. (2008). Opioides y Gabapentoides en el Tratamiento de la Fibromialgia. Revista El Dolor 2008;49: 11-4.

Leiva, N. y Soto A. (2003). Estudio de prevalencia de Fibromialgia en mujeres con Artritis Reumatoidea y Lupus Eritematoso Sistémico pertenecientes al policlínico de reumatología del Hospital del Salvador. Cibertesis. Universidad de Chile. Facultad de Medicina. Escuela de Kinesiología.

Ubago M, Ruiz P, Bermejo M, de Labry A, Castaño J,. (2005). Características clínicas y psicosociales de personas con fibromialgia. Repercusión del diagnóstico sobre sus actividades. Rev Esp Salud Pública 2005; 79:683-95.

Burckhardt CS, Clark SR, Bennett RM. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. J Rheumatol. 1991;18 :728-33.

Monterde S, Salvat I, Montull S, Fernández-Ballart J,. (2004). Validación de la versión española del Fibromyalgia Impact Questionnaire. Rev Esp Reumatol. 2004;31:507-13.

Rivera J, González T,. (2004). The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004;22: 554-60.

Esteves-Vives J., Batlle E,. (2006). Evaluación de pacientes con fibromialgia. Estudio comparativo de 4 versiones españolas del FIQ. Reumatol Clin. 2006;(6): 283-8

Esteve-Vives J, Rivera J, Salvat M, De gracia Blanco M, Alegre de Miquel C,. (2007). Propuesta de una versión de consenso del FIQ para la población española. Reumatol Clin. 2007;3(1): 21-4

Araya, P., Yáñez, L. (2006). Evaluación de la calidad de vida de pacientes mastectomizadas, tratadas en el Instituto Nacional del Cáncer entre los años 2003 y 2005. Cibertesis. Universidad de Chile. Facultad de Medicina. Escuela de Kinesiología.

Alegre de Miquel C, Alejandra-Pereda C, Betina-Nishishinya M, Rivera J. (2005). Revisión sistemática de las intervenciones farmacológicas en la fibromialgia. Med Clin (Barc). 2005;125(20): 784-7

Rivera J, Maratalla Justo C, Valdepeñas Moraleda F, García Velayos Y, Osés Puche JJ, Ruiz Zubero J, et al. (2004). Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach. Arthritis Rheum. 2004;51: 184-92.

Busch, AJ., Barber, KAR., Overend, TJ., Peloso, PMJ. y Schachter, CL.(2008) Ejercicio para el tratamiento del síndrome de fibromialgia (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.)

Tomas-Carus P, Gusi N, Leal A, García Y, Ortega A,. (2007). El tratamiento para la fibromialgia con ejercicio físico en agua caliente reduce el impacto de la enfermedad en la salud física y mental de mujeres afectadas. Reumatol Clin. 2007;3(1): 33-7

Kelley G, Kelley K, Hootman J and Jones D. (2010). Exercise and global wellbeing in community-dwelling adults with fibromyalgia: a systematic review with meta-analysis. BMC Public Health 2010, 10: 198

Kroese, M. et al. (2008). The feasibility and efficacy of a multidisciplinary intervention with aftercare meetings for fibromialgia. Clin Rheumatol (2009) 28: 923-9.